Time-Sensitive Research to Assess the Effects of Reproductive Health Policy on the Health Outcomes of People with Chronic Diseases
评估生殖健康政策对慢性病患者健康结果影响的时间敏感研究
基本信息
- 批准号:10768227
- 负责人:
- 金额:$ 68.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-15 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AdvertisingAffectAgeBirthCardiovascular DiseasesCaringChronicChronic DiseaseClinicalComplexContraceptive methodsDangerousnessDataDecision MakingDisabled PersonsDiscipline of obstetricsDiseaseDrug PrescriptionsEligibility DeterminationEpidemiologyEquityFamily PlanningFemaleHealthHealth PolicyHealth ServicesHealthcareIndividualInterviewLegalLifeLow incomeMalignant NeoplasmsMaternal MortalityMedicaidMedicalMedicineOutcomeOutcome AssessmentPatient Outcomes AssessmentsPatientsPersonal SatisfactionPersonsPharmaceutical PreparationsPharmacy facilityPhysiciansPoliciesPopulationPregnancyPregnancy OutcomePrimary CareProceduresPublic HealthRecommendationRecording of previous eventsRegulationReportingReproductive HealthResearchRespondentRiskSamplingSurveysSystemic Lupus ErythematosusTeratogensTimeTravelWomen&aposs Healthabortionadverse pregnancy outcomechild bearingclinical centerclinical practicecourtexperiencefetalhealth equityhealth practicehealthy pregnancyhigh riskindexingmultidisciplinaryperson centeredpopulation basedpregnantrecruitsearch enginesevere maternal morbiditysocialsocioeconomicsunintended pregnancy
项目摘要
ABSTRACT
In June 2022, the U.S. Supreme Court’s ruling in Dobbs v. Jackson Women’s Health overturned Roe v. Wade,
eliminating federal protections for abortion access nationwide. The Dobbs decision rapidly upended fifty years
of legal precedent and health policy. Fourteen states have banned abortion, state legislatures have introduced
85 bills to protect or restrict abortion access, and courts in eight states have temporarily blocked the passage of
abortion bans. Over 33.6 million people with childbearing capacity now live in states where abortion is banned
or likely to be heavily restricted. The effect of these rapidly changing policies on abortion access will be
profound, yet the consequences of these policies on public health indices are unknown. People with chronic
and complex medical conditions are particularly vulnerable to adverse health consequences as a result of
abortion policy. At baseline, these individuals are at high risk for severe maternal morbidity and maternal
mortality as compared to other birthing people. Prior to the Dobbs decision, abortion care allowed for life-
altering care among people whose underlying health conditions complicated healthy pregnancy. However, few
studies had described the impact of abortion on the health and well-being of individuals with chronic diseases;
thus, it is unclear how the Dobbs decision will impact their clinical outcomes. Our study, Investigating Time-
sensitive Reproductive Health Equity Post-Dobbs for Patients with ChronIc Disease (INTREPID), will evaluate
the time-sensitive impact of evolving abortion policies on the health and well-being of patients, particularly
those with chronic diseases that increase the risk of severe maternal morbidity and maternal mortality (e.g.,
cardiovascular disease, cancer, systemic lupus erythematosus); the clinical practice of physicians who care for
people with chronic diseases; and downstream clinical outcomes at a population level. We will use survey-
based, qualitative, and epidemiologic approaches to realize our Specific Aims, which are to: 1) Evaluate,
among people who are seeking abortion, who is able or not able to obtain a wanted abortion, and to assess their
longitudinal outcomes related to health and well-being; 2) Assess, among physicians, the impact of abortion
policy on medical decision-making and practice; and 3) Generate new evidence about the impact of abortion
policy on population-based pregnancy outcomes (e.g., severe maternal morbidity, maternal mortality) and
healthcare-related outcomes (e.g., contraception and teratogenic medication prescribing). The INTREPID
research team has multidisciplinary expertise in medicine, obstetrics, family planning research, health equity,
health policy, and epidemiology. Our project seeks to inform health policy that will optimize reproductive
healthcare and clinical outcomes in the post-Dobbs era.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mehret Birru Talabi其他文献
Development of ReproKnow, a reproductive knowledge assessment for women with rheumatic diseases
开发 ReproKnow,针对患有风湿病的女性进行生殖知识评估
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:2.2
- 作者:
Mehret Birru Talabi;M. Clowse;S. Blalock;G. Switzer;Lanskikh Yu;Alaina Chodoff;S. Borrero - 通讯作者:
S. Borrero
Medication decision making under uncertainty: Considering chronic disease and pregnancy potential
不确定情况下的药物决策:考虑慢性病和怀孕的可能性
- DOI:
10.1016/j.semperi.2025.152057 - 发表时间:
2025-04-01 - 期刊:
- 影响因子:3.200
- 作者:
Mehret Birru Talabi;Rebekah Miller;Tamar Krishnamurti - 通讯作者:
Tamar Krishnamurti
Antirheumatic medications in pregnancy and breastfeeding.
妊娠期和哺乳期的抗风湿药物。
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:5.1
- 作者:
Mehret Birru Talabi;M. Clowse - 通讯作者:
M. Clowse
A Framework for Femtech: Guiding Principles for Developing Digital Reproductive Health Tools in the United States
女性科技框架:美国开发数字生殖健康工具的指导原则
- DOI:
10.2196/preprints.36338 - 发表时间:
2022 - 期刊:
- 影响因子:7.4
- 作者:
T. Krishnamurti;Mehret Birru Talabi;L. Callegari;T. Kazmerski;S. Borrero - 通讯作者:
S. Borrero
Overturning Roe v. Wade: Toppling the Practice of Rheumatology
推翻罗伊诉韦德案:推翻风湿病学实践
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:13.3
- 作者:
B. Bermas;I. Blanco;Ashira Blazer;M. Clowse;C. Edens;R. Ramsey‐Goldman;Mehret Birru Talabi - 通讯作者:
Mehret Birru Talabi
Mehret Birru Talabi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mehret Birru Talabi', 18)}}的其他基金
Development of a novel, patient-centered measure of reproductive autonomy in the healthcare context
在医疗保健环境中开发一种新颖的、以患者为中心的生殖自主权测量方法
- 批准号:
10508732 - 财政年份:2022
- 资助金额:
$ 68.17万 - 项目类别:
Development of a novel, patient-centered measure of reproductive autonomy in the healthcare context
在医疗保健环境中开发一种新颖的、以患者为中心的生殖自主权测量方法
- 批准号:
10670966 - 财政年份:2022
- 资助金额:
$ 68.17万 - 项目类别:
Investigating Pathways to Optimal Reproductive Outcomes Among Women with Rheumatic Diseases
研究患有风湿病的女性获得最佳生殖结果的途径
- 批准号:
10683187 - 财政年份:2020
- 资助金额:
$ 68.17万 - 项目类别:
Investigating Pathways to Optimal Reproductive Outcomes Among Women with Rheumatic Diseases
研究患有风湿病的女性获得最佳生殖结果的途径
- 批准号:
10263313 - 财政年份:2020
- 资助金额:
$ 68.17万 - 项目类别:
Investigating Pathways to Optimal Reproductive Outcomes Among Women with Rheumatic Diseases
研究患有风湿病的女性获得最佳生殖结果的途径
- 批准号:
10478252 - 财政年份:2020
- 资助金额:
$ 68.17万 - 项目类别:
Investigating Pathways to Optimal Reproductive Outcomes Among Women with Rheumatic Diseases
研究患有风湿病的女性获得最佳生殖结果的途径
- 批准号:
10054710 - 财政年份:2020
- 资助金额:
$ 68.17万 - 项目类别:
相似国自然基金
巨噬细胞CD38通过调节肾小管NAD+水平影响年龄相关急性肾损伤易感性的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
恒星模型中氧元素丰度的变化对大样本F、G、K矮星年龄测定的影响
- 批准号:12303035
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
中国东部地区大气颗粒物的年龄分布特征及其影响因素的模拟研究
- 批准号:42305193
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
年长员工数字技术工作不安全感的前因组态与影响后效研究
- 批准号:72302162
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于堆叠式集成学习探索人居环境对生物学年龄的影响
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
运动状态下代谢率的年龄变化特征及对人体热舒适的影响研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
跨区域视角下人口年龄结构对家庭碳足迹的影响研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 68.17万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 68.17万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 68.17万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 68.17万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 68.17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 68.17万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 68.17万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 68.17万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 68.17万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 68.17万 - 项目类别:
Miscellaneous Programs